Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00572299 · ClinicalTrials.gov registry record
Glucocorticoids Promote Osteoclast Survival
A clinical trial, sponsored by University of Arkansas.
- Terminated
- Registry status
- 3
- Enrollment target
NCT00572299: Clinical Trial study, sponsored by University of Arkansas.
NCT00572299 is a clinical trial that was terminated before completion, run by University of Arkansas. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00572299 was terminated before completion, sponsored by University of Arkansas.
- TERMINATED
- Registry status
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the difference in response to bisphosphonate therapy in patients receiving excess glucocorticoids compared to patients with postmenopausal or male osteoporosis. Bisphosphonates are approved by the FDA for the treatment of postmenopausal women and osteoporotic men who are at high risk of fracture and in men and women with excess glucocorticoid administration.
Interventions
- DRUG alendronate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2004-01 |
| Est. Completion | 2010-05 |
Why NCT00572299 stopped before completion
NCT00572299 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which alendronate is the first listed.
NCT00572299 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00572299 about?
NCT00572299 is a clinical study titled "Glucocorticoids Promote Osteoclast Survival". The purpose of this study is to determine the difference in response to bisphosphonate therapy in patients receiving excess glucocorticoids compared to patients with postmenopausal or male osteoporosis. Bisphosphonates are approved by the FDA for the treatment of postmenopausal women and osteoporoti...
What is the current status of trial NCT00572299?
This trial is currently terminated. The enrollment target is 3 participants. The study started on 2004-01. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00572299?
The interventions under investigation include: alendronate (DRUG).
Who is sponsoring clinical trial NCT00572299?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia